Immediate Impact

6 from Science/Nature 62 standout
Sub-graph 1 of 23

Citing Papers

Synthesis of Azabicyclo[3.1.1]heptenes Enabled by Catalyst-Controlled Annulations of Bicyclo[1.1.0]butanes with Vinyl Azides
2024 Standout
FGFR-targeted therapeutics: clinical activity, mechanisms of resistance and new directions
2024 Standout
1 intermediate paper

Works of Ronald E. Savage being referenced

A Phase 1 study of ARQ 087, an oral pan-FGFR inhibitor in patients with advanced solid tumours
2017
Discovery of 3-(3-(4-(1-Aminocyclobutyl)phenyl)-5-phenyl-3H-imidazo[4,5-b]pyridin-2-yl)pyridin-2-amine (ARQ 092): An Orally Bioavailable, Selective, and Potent Allosteric AKT Inhibitor
2016

Author Peers

Author Last Decade Papers Cites
Ronald E. Savage 631 338 269 331 43 1.3k
Kiyoshi Okamoto 589 503 324 214 52 1.7k
Jingrong Jean Cui 716 528 448 451 16 1.3k
Akihiko Tsuruoka 649 513 381 289 30 1.6k
Melissa Dumble 738 405 139 263 28 1.3k
Haitian Quan 485 651 375 109 30 1.3k
Benedetta Peruzzi 572 209 137 156 36 1.1k
Fatima Rangwala 603 546 280 152 34 1.6k
Annette Frost 460 736 486 205 29 1.3k
Francisco Javier Ramos 764 616 414 75 40 1.4k
David R. Gandara 567 819 500 138 47 1.6k

All Works

Loading papers...

Rankless by CCL
2026